RNR

Renaissancere Holdings Ltd

Add to Watchlist

Advanced Chart

246.100

+3.030(+1.250%)

Overview
Forecast
Valuation

Line

Candle

YTD

High

247.2995

Open

243.340

VWAP

246.18

Vol

421.17K

Mkt Cap

11.97B

Low

243.200

Amount

103.68M

EV/EBITDA(TTM)

8.58

Total Shares

52.88M

20.39B

EV/OCF(TTM)

5.60

P/S(TTM)

1.00

RenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance. The Company provides property, casualty and specialty reinsurance and certain insurance solutions to customers, principally through intermediaries. The Company has two segments. The Property segment is comprised of catastrophe and other property reinsurance and insurance written on behalf of its operating subsidiaries, joint ventures, and managed funds. The Casualty and Specialty segment is comprised of casualty and specialty reinsurance and insurance written on behalf of its operating subsidiaries, joint ventures, and managed funds. The Company writes catastrophe reinsurance and insurance coverage protecting against natural and man-made catastrophes, such as earthquakes, hurricanes, typhoons and tsunamis, winter storms, freezes, floods, fires, windstorms, tornadoes, explosions and acts of terrorism, among others. Its subsidiaries include Renaissance Reinsurance Ltd., Validus Reinsurance Ltd. and others.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

1.80B

+2.97%

8.204

+1.79%

2.21B

+2.37%

4.591

-55.12%

2.96B

+4.39%

9.675

-22.04%

Estimates Revision

The market is revising No Change the revenue expectations for RenaissanceRe Holdings Ltd. (RNR) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 5.73%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+5.73%

In Past 3 Month

11 Analyst Rating

13.94% Upside

Wall Street analysts forecast RNR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for RNR is 280.40 USD with a low forecast of 231.00 USD and a high forecast of 426.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

3 Hold

2 Sell

Moderate Buy

13.94% Upside

Current: 246.100

Low

231.00

Averages

280.40

High

426.00

13.94% Upside

Current: 246.100

Low

231.00

Averages

280.40

High

426.00

Keefe, Bruyette & Woods

Meyer Shields

Buy

Maintains

$279 → $282

2025-04-29

Reason

Keefe, Bruyette & Woods

Meyer Shields

Price Target

$279 → $282

2025-04-29

Maintains

Buy

Reason

Keefe Bruyette analyst Meyer Shields raised the firm's price target on RenaissanceRe to $282 from $279 and keeps an Outperform rating on the shares.

Morgan Stanley

Michael Phillips

Hold

Buy

Upgrades

$235 → $275

2025-04-25

Reason

Morgan Stanley

Michael Phillips

Price Target

$235 → $275

2025-04-25

Upgrades

Hold

Buy

Reason

Morgan Stanley upgraded RenaissanceRe to Overweight from Equal Weight with a price target of $275, up from $235. The firm sees temporary headwinds currently pressuring the stock, but with shares down about 8% year-to-date, and underperforming the broader property and casualty space, the firm believes the stock is now undervalued. RenRe should be able to weather the headwinds into 2026 and the firm believes valuation will normalize higher, with a favorable risk/reward skew, the analyst tells investors.

JMP Securities

Karol Chmiel

Hold

Reiterates

n/a

2025-04-24

Reason

JMP Securities

Karol Chmiel

Price Target

n/a

2025-04-24

Reiterates

Hold

Reason

Jefferies

Andrew Andersen

Hold

Maintains

$266 → $265

2025-04-11

Reason

Jefferies

Andrew Andersen

Price Target

$266 → $265

2025-04-11

Maintains

Hold

Reason

Jefferies analyst Andrew Andersen lowered the firm's price target on RenaissanceRe to $265 from $266 and keeps a Hold rating on the shares. Tariffs are a "manageable earnings risk for the well-capitalized and defensive" property and casualty group, the analyst tells investors in a research note. The firm says auto insurers have some ability to re-price quickly, and loss cost inflation concerns are already top of mind for the commercial group, "with any tariff impact likely to spur further discipline." It sees no notable effect in Q1 and remains most constructive on personal lines.

Barclays

Alex Scott

Sell

Maintains

$234 → $231

2025-04-11

Reason

Barclays

Alex Scott

Price Target

$234 → $231

2025-04-11

Maintains

Sell

Reason

Barclays lowered the firm's price target on RenaissanceRe to $231 from $234 and keeps an Underweight rating on the shares as part of a Q1 earnings preview for the insurance group. With life earnings facing challenges Barclays favors group benefits, excess capital, and "cheap" cash flows, the analyst tells investors in a research note. The firm says the sector is "navigating uncertainty."

Wells Fargo

Elyse Greenspan

Buy

Maintains

$277 → $271

2025-04-10

Reason

Wells Fargo

Elyse Greenspan

Price Target

$277 → $271

2025-04-10

Maintains

Buy

Reason

Wells Fargo lowered the firm's price target on RenaissanceRe to $271 from $277 and keeps an Overweight rating on the shares. The firm notes that the quarter lost a little luster with the tariff backdrop and Wells thinks a bigger focus will be on any views of tariffs/ensuring macro backdrop.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Renaissancere Holdings Ltd (RNR.N) is 7.45, compared to its 5-year average forward P/E of 14.03. For a more detailed relative valuation and DCF analysis to assess Renaissancere Holdings Ltd 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

14.03

Current PE

7.45

Overvalued PE

39.59

Undervalued PE

-11.53

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

1.23

Current PS

1.13

Overvalued PS

1.51

Undervalued PS

0.95